 |
|
Clinical efficacy of erlotinib, a salvage treatment for non-small cell lung cancer patients following gefitinib failure
Kyoung Min Cho, Bhumsuk Keam, Tae Min Kim, Se-Hoon Lee, Dong-Wan Kim, Dae Seog Heo
Korean J Intern Med. 2015;30(6):891-898. Published online 2015 Oct 30 DOI: https://doi.org/10.3904/kjim.2015.30.6.891
|
|
Citations to this article as recorded by
 A Case Report of Recurrent L858R Mutation Non-Small-Cell Lung Cancer with Brain Metastases Treated with Erlotinib and Traditional Korean Medicine After Failure with Gefitinib
Jung-min Yang, Kwon-jun Jang, Woo-seok Hwang
The Journal of Internal Korean Medicine.2022; 43(5): 838. CrossRef Erlotinib as a salvage treatment after gefitinib failure for advanced non-small-cell lung cancer patients with brain metastasis
Yong Dong, Qijun Li, Qian Miao, Da Li
Medicine.2021; 100(25): e26450. CrossRef Chemotherapy should be performed in epidermal growth factor receptor mutation-positive lung adenocarcinoma patients who had progressive disease to the first epidermal growth factor receptor-tyrosine kinase inhibitor
Kosuke Kashiwabara, Shinji Fujii, Shinsuke Tsumura, Kazuhiko Sakamoto
Anti-Cancer Drugs.2020; 31(9): 959. CrossRef Re-challenge of afatinib after 1st generation EGFR-TKI failure in patients with previously treated non-small cell lung cancer harboring EGFR mutation
Ou Yamaguchi, Kyoichi Kaira, Atsuto Mouri, Ayako Shiono, Kosuke Hashimoto, Yu Miura, Fuyumi Nishihara, Yoshitake Murayama, Kunihiko Kobayashi, Hiroshi Kagamu
Cancer Chemotherapy and Pharmacology.2019; 83(5): 817. CrossRef Naesohwangryeon-tang Induced Apoptosis and Autophagy in A549 Human Lung Cancer Cells
Hong Jae Kim, Jin-Woo Jeong, Cheol Park, Yung Hyun Choi, Su Hyun Hong
Journal of Pharmacopuncture.2019; 22(4): 269. CrossRef Treatment of Hominis placenta pharmacopuncture for a patient with mild neurocognitive disorder: Case report
Yunna Kim, Yoon Ji Eom, Seung-Hun Cho
Journal of Pharmacopuncture.2019; 22(4): 279. CrossRef Gefitinib
Reactions Weekly.2016; 1629(1): 123. CrossRef
|